Related Experiment Video
Updated: Jan 22, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
Validation of a low-cost, carbon dioxide-based cryoablation system for percutaneous tumor ablation
Bailey Surtees1, Sean Young1, Yixin Hu1
1Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America.
Abstract:
Breast cancer rates are rising in low- and middle-income countries (LMICs), yet there is a lack of accessible and cost-effective treatment. As a result, the cancer burden and death rates are highest in LMICs. In an effort to meet this need, our work presents the design and feasibility of a low-cost cryoablation system using widely-available carbon dioxide as the only consumable. This system uses an 8-gauge outer-diameter needle and Joule-Thomson expansion to percutaneously necrose tissue with cryoablation. Bench top experiments characterized temperature dynamics in ultrasound gel demonstrated that isotherms greater than 2 cm were formed. Further, this system was applied to mammary tumors in an in vivo rat model and necrosis was verified by histopathology. Finally, freezing capacity under a large heat load was assessed with an in vivo porcine study, where volumes of necrosis greater than 1.5 cm in diameter confirmed by histopathology were induced in a highly perfused liver after two 7-minute freeze cycles. These results demonstrate the feasibility of a carbon-dioxide based cryoablation system for improving solid tumor treatment options in resource-constrained environments.
Related Concept Videos
Carbon-dioxide Fixation
Carbon Dioxide Transport in the Blood
Forms of CO2 Transport
1. Dissolved in plasma: A small percentage (7-10%) of CO2 is transported and dissolved directly in the plasma.
2. Carbaminohemoglobin: Just over 20% of CO2 is chemically bound to...
The Carbon Cycle
Reliability and Validity
Carbon Skeletons
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...

